PMI

Picard Medical, Inc.

There isn't enough reported data to score PMI yet.

PMI Fundamentals

MetricStatus
Strong
Weak
Weak
Unavailable

PMI's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

PMI PE Valuation

PMI has no meaningful PE right now: it lost money over the past year.

PMI Forward outlook

There aren't enough analyst estimates for PMI to show an outlook.

PMI Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $7.85 on Nov 12.

There is not enough scenario data to assess PMI's risk to reward.

PMI Earnings Per Share

Q3 2024: $-14.48Q4 2024: $-16.37Q1 2025: $-18.95Q2 2025: $-20.78Q3 2025: $-25.50
Q3 2024: $-14.48Q4 2024: $-16.37Q1 2025: $-18.95Q2 2025: $-20.78Q3 2025: $-25.50
QuarterTTM EPSYoY
Q3 2025-$25.50-$11.02

PMI lost $25.50 per share over the past year, a bigger loss than the year before.

PMI Quarterly Revenue

Q3 2023: --Q4 2023: $826,000Q1 2024: $2MQ2 2024: $694,000Q3 2024: $881,000Q4 2024: $836,000Q1 2025: $620,000Q2 2025: $2MQ3 2025: $1MQ4 2025: $1MQ1 2026: $1MQ2 2026: $3M
Q3 2023: --Q4 2023: $826,000Q1 2024: $2MQ2 2024: $694,000Q3 2024: $881,000Q4 2024: $836,000Q1 2025: $620,000Q2 2025: $2MQ3 2025: $1MQ4 2025: $1MQ1 2026: $1MQ2 2026: $3M
QuarterRevenueYoY
Q2 2026$3M+39%
Q1 2026$1.2M+85%
Q4 2025$1M+21%
Q3 2025$1.2M+35%
Q2 2025$2.1M+207%
Q1 2025$620K-69%
Q4 2024$836K+1.2%

PMI's revenue has grown year over year for five quarters in a row: $3M last quarter, up 39% from the same quarter a year ago.

PMI Free Cash Flow

Q3 2023: −$2MQ4 2023: −$4MQ1 2024: −$2MQ2 2024: −$4MQ3 2024: −$3MQ4 2024: −$3MQ1 2025: −$2MQ2 2025: --Q3 2025: −$7MQ4 2025: −$4MQ1 2026: −$4MQ2 2026: −$1M
Q3 2023: −$2MQ4 2023: −$4MQ1 2024: −$2MQ2 2024: −$4MQ3 2024: −$3MQ4 2024: −$3MQ1 2025: −$2MQ2 2025: --Q3 2025: −$7MQ4 2025: −$4MQ1 2026: −$4MQ2 2026: −$1M
QuarterFree cash flowYoY
Q1 2026-$3.8M-$1.6M
Q4 2025-$4.4M-$1.2M
Q3 2025-$6.5M-$3.9M
Q1 2025-$2.2M+$14K
Q4 2024-$3.2M+$709K
Q3 2024-$2.6M-$199K
Q2 2024-$3.9M-$1.9M
Q1 2024-$2.3M+$129K

PMI has burned cash in almost every quarter: −$16M over the past year, against −$12M the year before.

PMI Total Shares

Q4 2023: 1MQ1 2024: 1MQ2 2024: 1MQ3 2024: 1MQ4 2024: 1MQ1 2025: 1MQ2 2025: 1MQ3 2025: 1MQ1 2026: 1MQ2 2026: 2M
Q4 2023: 1MQ1 2024: 1MQ2 2024: 1MQ3 2024: 1MQ4 2024: 1MQ1 2025: 1MQ2 2025: 1MQ3 2025: 1MQ1 2026: 1MQ2 2026: 2M
PeriodChange %Net change
Quarterly+25%+367K shares
1 year+29%+415K shares

PMI has 2M diluted shares, up 29% from a year ago.

PMI Net Leverage

PMI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

PMI Weekly Momentum

MetricValueStatus
RSI46.9Neutral
Stochastic36.9Neutral

PMI's weekly RSI is 47 (neutral) and its Stochastic is 37 (neutral).

PMI PE vs Healthcare Sector

PMI has no meaningful PE right now: it lost money over the past year.

PMI Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$8.123.3% below
20 week MA$6.5420% above
50 week MA$36.779% below

PMI's trend is mixed: it's above one of its three weekly moving averages, and 79% below its 50-week average.

PMI Yearly ROI

YearStart priceEnd priceROI
2025$229.5$98.5-57%
2026 YTD$98.5$7.85-92%

PMI has finished every year since 2025 lower, and it's down 92% so far in 2026.

Give your agent the market.

Get API key